Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History AVXL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics AVXL

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Anavex Life Sciences Corp

AVXL
Current price
9.30 USD +0.3 USD (+3.33%)
Last closed 9.09 USD
ISIN US0327973006
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 770 908 288 USD
Yield for 12 month +120.90 %
1Y
3Y
5Y
10Y
15Y
AVXL
21.11.2021 - 28.11.2021

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States. The company's lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. It also provides ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York. Address: 630 5th Avenue, New York, NY, United States, 10111

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

34.33 USD

P/E ratio

Dividend Yield

Financials AVXL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures AVXL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

EBITDA
Operating Margin TTM
Price to Earnings
Return On Assets TTM -25.44 %
PEG Ratio
Return On Equity TTM -40.17 %
Wall Street Target Price 34.33 USD
Revenue TTM
Book Value 1.17 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.56 USD
Diluted Eps TTM -0.56 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation AVXL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 3.84
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -5.54
Price Book MRQ 7.73

Technical indicators AVXL

For 52 weeks

3.78 USD 14.44 USD
50 Day MA 8.44 USD
Shares Short Prior Month 24 099 499
200 Day MA 8.19 USD
Short Ratio 27.03
Shares Short 25 029 355
Short Percent 30.31 %